These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 212990)
1. Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co-V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-Atm) for DNA virus replication. Sloan BJ; Kielty JK; Miller FA Ann N Y Acad Sci; 1977 Mar; 284():60-80. PubMed ID: 212990 [TBL] [Abstract][Full Text] [Related]
2. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor. Falcon MG; Jones BR J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039 [TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus. Williams BB; Lerner AM J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine). Borondy PE; Chang T; Maschewske E; Glazko AJ Ann N Y Acad Sci; 1977 Mar; 284():9-20. PubMed ID: 280160 [No Abstract] [Full Text] [Related]
5. Adenine arabinoside inhibition of adenovirus replication enhanced by an adenosine deaminase inhibitor. Wigand R J Med Virol; 1979; 4(1):59-65. PubMed ID: 119038 [TBL] [Abstract][Full Text] [Related]
6. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice. Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863 [TBL] [Abstract][Full Text] [Related]
7. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase. Plunkett W; Cohen SS Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161 [No Abstract] [Full Text] [Related]
8. Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus. Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R Antimicrob Agents Chemother; 1974 Nov; 6(5):630-6. PubMed ID: 15825318 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside. Lambe CU; Resetar A; Spector T; Koszalka GW; Nelson DJ Antimicrob Agents Chemother; 1992 Feb; 36(2):353-60. PubMed ID: 1318679 [TBL] [Abstract][Full Text] [Related]
10. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. Champney KJ; Lauter CB; Bailey EJ; Lerner AM J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024 [TBL] [Abstract][Full Text] [Related]
11. Effect of an adenosine deaminase inhibitor on the uptake and metabolism of arabinosyl adenine (Vidarabine) by intact human erythrocytes. Chang T; Glazko AJ Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):127-40. PubMed ID: 935646 [TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor. Schwartz PM; Shipman C; Drach JC Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947 [TBL] [Abstract][Full Text] [Related]
13. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues. North TW; Cohen SS Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993 [TBL] [Abstract][Full Text] [Related]
14. Carbocyclic arabinosyladenine, an adenosine deaminase resistant antiviral agent. Vince R; Daluge S J Med Chem; 1977 Apr; 20(4):612-3. PubMed ID: 191615 [No Abstract] [Full Text] [Related]
15. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells. Plunkett W; Cohen SS Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475 [TBL] [Abstract][Full Text] [Related]
16. Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures. Bryson YJ; Kronenberg LH Antimicrob Agents Chemother; 1977 Feb; 11(2):299-306. PubMed ID: 848937 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues. Plunkett W Ann N Y Acad Sci; 1985; 451():150-9. PubMed ID: 3907452 [No Abstract] [Full Text] [Related]
18. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine. Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608 [TBL] [Abstract][Full Text] [Related]
19. Derivatives of 3'- and 5'-deoxyadenosine: their inhibitory activity against DNA viruses. Grytzmann B; Morr M; Wigand R Chemotherapy; 1980; 26(5):316-22. PubMed ID: 6967001 [TBL] [Abstract][Full Text] [Related]
20. 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus. Koszalka GW; Averett DR; Fyfe JA; Roberts GB; Spector T; Biron K; Krenitsky TA Antimicrob Agents Chemother; 1991 Jul; 35(7):1437-43. PubMed ID: 1656862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]